PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS
Arya Bazargani, Mohammad Hejazi, Matthew Fernandez, Arthur Cordeiro, Johanna Tsala Ebode, Nastassja A. Lewinski, Sandro da Rocha, Laleh Golshahi
Topics & Concepts
ElvitegravirAtazanavirSolid lipid nanoparticleNasal administrationPharmacologyMedicineAntiretroviral therapyHuman immunodeficiency virus (HIV)VirologyDrugViral loadAdvanced Drug Delivery SystemsRNA Interference and Gene DeliveryAdvancements in Transdermal Drug Delivery